The 2021 Tennessee Emerging Infections Program Scientific Presentation Day was held virtually on Oct. 7, 2021. Researchers presented on a variety of disease surveillance topics including COVID-19 vaccines and trends, wastewater surveillance of COVID-19, HPV and foodborne illness. Watch the full event below or on YouTube.
The Department of Health Policy hosted its Research Into Policy and Practice Lecture Series on Aug. 24, which covered proposed reforms to Tenncare, which would overhaul the state's Medicaid program and replace it with a modified aggregate cap model. Watch the webinar, moderated by Melinda Buntin, PhD, Mike Curb Professor of Health Policy and Chair of the Department here. Panelists include Kinika Young, Senior Director of Health Policy at the Tennessee Justice Center and Mandy Pellegrin, Policy Director at the Sycamore Institute.
A new study from researchers at Vanderbilt University Medical Center of all deliveries covered by Tennessee’s Medicaid program from 2009-16 (almost 315,000 mother-infant pairs) finds wide disparities in pregnant women receiving medications for opioid-use disorder – medications which have been shown to reduce risk of overdose death and improve pregnancy outcomes.
After a 2020 Vanderbilt University Medical Center study showed women have a difficult time accessing treatment for opioid use disorder (OUD), investigators analyzed comments received from the study’s participants to further shed light on barriers to care, which included everything from long on-hold times to difficult interactions with clinic receptionists during phone calls seeking appointments.
A new report from the Centers for Disease Control and Prevention (CDC) and academic researchers has found that COVID-19 vaccines are 94% effective at preventing hospitalization for COVID-19. The findings are among the first to demonstrate high effectiveness of COVID-19 vaccines in the U.S. population of older adults, and included data collected from January 2021 through March 2021. The study evaluated the Pfizer/BioNTech and Moderna vaccines, the most commonly used during the study period.